Form 4: NeuroOne Medical Technologies Corp: Officer Mertens Disposes of Shares to Cover Tax Obligations
SEC Form 4
Chief Technology Officer Steve Mertens disposed of 7,376 shares of NeuroOne Medical Technologies Corp to satisfy tax obligations related to vesting restricted stock units.
Summary
- On February 18, 2025, Steve Mertens, Chief Technology Officer of NeuroOne Medical Technologies Corp, disposed of 7,376 shares of common stock.
- The transaction was executed to cover tax obligations arising from the vesting of restricted stock units.
- The shares were disposed of at a price of $1.16 per share.
- Following the transaction, Mertens directly owns 164,047 shares of NeuroOne Medical Technologies Corp.
Sentiment
Score: 6
Explanation: The sentiment is neutral as the transaction is a standard procedure for covering tax obligations. It doesn't indicate a positive or negative outlook for the company.
Industry Context
This transaction is a routine occurrence where company executives sell shares to cover tax obligations arising from stock vesting. It doesn't necessarily reflect a negative outlook on the company's future prospects.
Stakeholder Impact
- The transaction is unlikely to have a significant impact on stakeholders as it is a routine sale to cover tax obligations.
Key Dates
| Date | Description |
|---|---|
| 02/18/2025 | Date of transaction: Steve Mertens disposed of shares. |
| 02/20/2025 | Date of signature on the Form 4 filing. |
Disclaimer:The information provided here is for general informational purposes only and does not constitute financial advice, recommendation, or endorsement of any kind. It may contain errors or omissions. You should not rely on this information to make financial decisions. Always seek the advice of a qualified financial professional before making any investment or financial decisions. Use of this information is at your own risk.